||Registry of biomedical companies:
  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 588 active entries
7010 NW 100 Dr. Blg. A, Suite 101
Houston, 77092, USA
Phone: 713-939-1833 X300
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Pathobiotek Diagnostics Inc., (PDI) is a research and development company engaged in the discovery, identification, and
characterization of novel microbial agents. Among the microbial agents that scientists at PDI have identified is an organism
that may be associated with symptoms in multiple sclerosis (MS) patients. This organism has not been previously
characterized or associated with any specific human disease. PDI has conducted studies that have shown a 100% correlation
between clinical improvement and reduction of levels of organism in MS patients. A similar correlation with this organism
has been seen in the treatment of other disorders, such as Chronic Fatigue Syndrome (CFS) and certain autoimmune
WEB SITE www.pathobiotek.com
Last update of this entry: August 08, 2000
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking